LoConte, N. K., Holen, K. D., Schelman, W. R., Mulkerin, D. L., Deming, D. A., Hernan, H. R., . . . Lubner, S. J. (2012). A phase I study of sorafenib, oxaliplatin and two days of high dose capecitabine in advanced pancreatic and biliary tract cancer: A Wisconsin Oncology Network Study.
Chicago Style CitationLoConte, Noelle K., et al. A Phase I Study of Sorafenib, Oxaliplatin and Two Days of High Dose Capecitabine in Advanced Pancreatic and Biliary Tract Cancer: A Wisconsin Oncology Network Study. 2012.
MLA CitationLoConte, Noelle K., et al. A Phase I Study of Sorafenib, Oxaliplatin and Two Days of High Dose Capecitabine in Advanced Pancreatic and Biliary Tract Cancer: A Wisconsin Oncology Network Study. 2012.
Warning: These citations may not always be 100% accurate.